These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 16728552

  • 1. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.
    Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D.
    Eur J Endocrinol; 2006 Jun; 154(6):907-16. PubMed ID: 16728552
    [Abstract] [Full Text] [Related]

  • 2. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial.
    Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI, Postmenopausal Estrogen/Progestin Intervention Trial.
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1646-52. PubMed ID: 12679451
    [Abstract] [Full Text] [Related]

  • 3. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women.
    Worsley R, Robinson PJ, Bell RJ, Moufarege A, Davis SR.
    Menopause; 2013 Jun; 20(6):640-5. PubMed ID: 23531683
    [Abstract] [Full Text] [Related]

  • 4. Associations of endogenous sex hormones and sex hormone-binding globulin with lipid profiles in aged Japanese men and women.
    Yasui T, Uemura H, Irahara M, Arai M, Kojimahara N, Okabe R, Ishii Y, Tashiro S, Sato H.
    Clin Chim Acta; 2008 Dec; 398(1-2):43-7. PubMed ID: 18755173
    [Abstract] [Full Text] [Related]

  • 5. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK, Zhang SF, Zou SE, Xia X, Xu LN.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [Abstract] [Full Text] [Related]

  • 6. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 7. Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy.
    Debing E, Peeters E, Duquet W, Poppe K, Velkeniers B, Van den Brande P.
    Eur J Endocrinol; 2007 Jun 11; 156(6):687-93. PubMed ID: 17535869
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress is associated with C-reactive protein in nondiabetic postmenopausal women, independent of obesity and insulin resistance.
    Park S, Kim M, Paik JK, Jang YJ, Lee SH, Lee JH.
    Clin Endocrinol (Oxf); 2013 Jul 11; 79(1):65-70. PubMed ID: 22816656
    [Abstract] [Full Text] [Related]

  • 9. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
    Rexrode KM, Manson JE, Lee IM, Ridker PM, Sluss PM, Cook NR, Buring JE.
    Circulation; 2003 Oct 07; 108(14):1688-93. PubMed ID: 12975257
    [Abstract] [Full Text] [Related]

  • 10. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men.
    Haffner SM, Mykkänen L, Valdez RA, Katz MS.
    J Clin Endocrinol Metab; 1993 Dec 07; 77(6):1610-5. PubMed ID: 8263149
    [Abstract] [Full Text] [Related]

  • 11. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA.
    Climacteric; 2008 Dec 07; 11(6):509-17. PubMed ID: 18991078
    [Abstract] [Full Text] [Related]

  • 12. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study.
    Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH, atherosclerosis risk in communities study.
    J Clin Endocrinol Metab; 2005 Feb 07; 90(2):1202-9. PubMed ID: 15546905
    [Abstract] [Full Text] [Related]

  • 13. Endogenous sex steroids and circulating homocysteine in healthy Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Rizos DA, Alexandrou A, Kountouris AV, Creatsas GC.
    Hormones (Athens); 2006 Feb 07; 5(1):35-41. PubMed ID: 16728383
    [Abstract] [Full Text] [Related]

  • 14. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.
    Ouyang P, Vaidya D, Dobs A, Golden SH, Szklo M, Heckbert SR, Kopp P, Gapstur SM.
    Atherosclerosis; 2009 May 07; 204(1):255-61. PubMed ID: 18849030
    [Abstract] [Full Text] [Related]

  • 15. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM, Jaspers L, Koster MP, Broekmans FJ, de Rijke YB, Franco OH, Laven JS, Kavousi M, Fauser BC.
    Hum Reprod; 2015 Oct 07; 30(10):2376-86. PubMed ID: 26269538
    [Abstract] [Full Text] [Related]

  • 16. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.
    Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I.
    Metabolism; 2012 Feb 07; 61(2):193-201. PubMed ID: 21820132
    [Abstract] [Full Text] [Related]

  • 17. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 18. Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women.
    Kumagai S, Kai Y, Sasaki H.
    J Atheroscler Thromb; 2001 Jan 18; 8(1):14-20. PubMed ID: 11686310
    [Abstract] [Full Text] [Related]

  • 19. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
    Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
    J Cardiovasc Pharmacol; 2006 Apr 18; 47(4):542-8. PubMed ID: 16680067
    [Abstract] [Full Text] [Related]

  • 20. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women.
    Davis SR, Robinson PJ, Moufarege A, Bell RJ.
    Clin Endocrinol (Oxf); 2012 Oct 18; 77(4):541-7. PubMed ID: 22106826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.